Lipoprotein(a) and incident peripheral artery disease in the Atherosclerosis Risk in Communities Study
Authors:
- Kaleb LemaKLKaleb Lema
- Emma K. StappESEmma K. Stapp
- Minghao KouMKMinghao Kou
- Shoshana H. BallewSBShoshana H. Ballew
- Ning DingNDNing Ding
- Ron C. HoogeveenRHRon C. Hoogeveen
- Christie M. BallantyneCBChristie M. Ballantyne
- Maya J. SalamehMSMaya J. Salameh
- Kunihiro MatsushitaKMKunihiro Matsushita
- Melinda C. PowerMPMelinda C. Power
- 17 November 2026
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 424
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Lipoprotein(a) Levels in Disaggregated Racial and Ethnic Subgroups Across Atherosclerotic Cardiovascular Disease Risk LevelsJACC: Advances, 2024
- Lipoprotein (a) and HypertensionCurrent Hypertension Reports, 2021
- Human Genetics and the Causal Role of Lipoprotein(a) for Various DiseasesCardiovascular Drugs and Therapy, 2016
- Lipoprotein (a) as a risk factor for ischemic stroke: A meta-analysisAtherosclerosis, 2015
- Validity of self-report of lipid medication use: The Atherosclerosis Risk in Communities (ARIC) StudyAtherosclerosis, 2015
- Risk Factors for Peripheral Arterial Disease Among Patients With Chronic Kidney DiseaseThe American Journal of Cardiology, 2012
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial InfarctionJAMA, 2009
- Novel Risk Factors for Systemic AtherosclerosisJAMA, 2001
- Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: Methods and initial two years' experienceJournal of Clinical Epidemiology, 1996
- Lipoprotein (a): A Risk Factor for Peripheral Vascular DiseaseAnnals of Vascular Surgery, 1993